Truvada is an anti-HIV drug that falls under the Nucleoside Reverse Transcriptase Inhibitors (NRTI) category of HIV medicines. Marketed my Gilead Sciences, Truvada was approved by the U.S. Food and Drug Administration (FDA) for use by the patients living with HIV in August 2004.
Truvada is a drug for the HIV-positive patients that must be combined with at least one other anti-HIV drug, usually with a Protease Inhibitor (PI) or a Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI). Truvada is a combination of two drugs, 300 mg of Viread and 200 mg of Emtriva. Both of these two drugs are active against the hepatitis B virus. Some doctors also prescribe Truvada to treat both hepatitis B and HIV, though this has not been approved by FDA.
Truvada is a tablet that the HIV patients take once a day, and can be taken with or without food. It is a preferred NRTI option, used in combination with the NNRTI, whereas, it is an alternative NRTI option when it is combined with Viramune or a Protease inhibitor. Truvada prevents HIV from altering the genetic material of healthy T-cells. It prevents the cell from producing new virus and decreases the amount of virus in the body.
There are some restrictions in taking Truvada. It should not be taken at the same time as Epivir or other combination tablets that contain Epivir. It cannot be used in combination with Videx/Videx EC. Those who are using Truvada in combination with Reyataz, have to be more careful, as the Viread in Truvada can decrease Teyatz level in the bloodstream and Reyataz can increase Viread levels in the bloodstream. In that situation, we need to consult with your physician who would suggest you a low dose of Norvir that can significantly boost the amount of Reyataz in the boodstream.
There may be some side effects in taking Truvada. If one experiences nausea, vomiting or unusual stomach discomfort, shortness of breath, yellowing of skin or eyes, he should immediately contact the physician. The Viread in Truvada can cause bone problem. The drug can be problematic to those who have kidney problems.
For more information on HIV/AIDS Drugs, please go through the website sitagita.
Will Naseeruddin Shah starer 'Johnday' break the records of 'A Wednesday'?
|No||19% | 13 votes|
|Never||57% | 39 votes|
|Yes||23% | 16 votes|
|Total Votes: 68|
|View all Polls|